Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Bleeding Stories

2014-04-17 08:28:45

- Three-year commitment of up to 20 million units per year of blood clotting medicines to treat hemophilia patients in developing countries BARCELONA, Spain, April 17, 2014 /PRNewswire/ -- Grifols, S.A. (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) today announced that it will donate up to 20 million units of coagulation therapies in each of the next three (3) years to the World Federation of Hemophilia (WFH). Grifols has been a proud supporter of the WFH and its noble efforts for nearly a...

2014-04-17 08:28:23

Donated coagulation factor supports WFH Global Alliance for Progress program KING OF PRUSSIA, Pa., April 17, 2014 /PRNewswire/ -- CSL Behring announced today that the company will continue its ongoing commitment to the global coagulation disorders community with a donation of product to the World Federation of Hemophilia (WFH). The donation, provided in connection with World Hemophilia Day on April 17, supports WFH's Global Alliance for Progress (GAP) program aimed at improving the...

2014-04-17 08:22:44

Inspirational video is launched on World Hemophilia Day to tell the story of one Canadian's triumph over adversity TORONTO, April 17, 2014 /CNW/ - Attitude makes you a hero; that's why John Schmitke, Vice President and Chairman of the Youth Committee at the Canadian Hemophilia Society, Manitoba Chapter, is working to empower and inspire those with hemophilia by sharing his own positive approach to living with this blood disorder. On World Hemophilia Day (April 17, 2014), John...

2014-04-16 08:32:37

6.9 million people have a bleeding disorder. 75 percent of them don't know it. MONTREAL, April 16, 2014 /PRNewswire/ -- Every year on April 17, World Hemophilia Day is observed around the world to increase awareness of hemophilia and other inherited bleeding disorders. In 2014, World Hemophilia Day's theme will encourage the younger generation of the global bleeding disorders community to "Speak out. Create change." "World Hemophilia Day is part of our critical effort to aid in...

2014-04-11 16:21:43

ORLANDO, Fla., April 11, 2014 /PRNewswire-iReach/ -- Bio-Stat LLC, the exclusive US distributor of CELOX(TM) hemostatic dressings manufactured by MedTrade Products Ltd., a UK based medical device company, today announced that the US Department of Defense's Committee for Tactical Combat Casualty Care (CoTCCC) has added CELOX(TM) Gauze to its guidelines for control of hemorrhage as approved hemostatic agents for military-wide use. Photo -...

2014-04-10 08:30:32

WESTPORT, Conn., April 10, 2014 /PRNewswire/ -- HemCon Medical Technologies, Inc. ("HemCon"), a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that the U.S. Department of Defense's Committee on Tactical Combat Casualty Care (CoTCCC) updated its guideline recommendations for control of severe external hemorrhage to include HemCon's ChitoGauze hemostatic chitosan-coated gauze...

2014-04-08 23:32:12

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today. Chicago, IL (PRWEB) April 08, 2014 The prescription drug safety advocates at DrugNews.net are alerting patients taking the blood thinner Pradaxa of new information on the site. As the number of lawsuits alleging the drug caused internal bleeding continue to rise, researchers have reported a possible antidote*. DrugNews is a free...

2014-04-02 15:37:00

Discovery could lead to more effective therapies to prevent heart attacks Right now, options are limited for preventing heart attacks. However, the day may come when treatments target the heart attack gene, myeloid related protein-14 (MRP-14, also known as S100A9) and defang its ability to produce heart attack-inducing blood clots, a process referred to as thrombosis. Scientists at Case Western Reserve School of Medicine and University Hospitals Case Medical Center have reached a...

2014-04-02 08:33:56

ATLANTA, April 2, 2014 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has received approval of its Investigational Device Exemption (IDE) for PerClot from the United States Food and Drug Administration (FDA). This approval allows CryoLife to begin its pivotal clinical trial to gain approval to commercialize PerClot in the U.S. The Company plans to begin enrollment in...

2014-03-24 08:28:01

The Approval of ALPROLIX is First Significant Advance in Hemophilia B Treatment in More Than 17 Years CAMBRIDGE, MA, March 24, 2014 /CNW/ - Biogen Idec (NASDAQ: BIIB) has announced that Health Canada approved ALPROLIX((TM) )[Coagulation Factor IX (Recombinant), Fc Fusion Protein], for the control and prevention of bleeding episodes and routine prophylaxis in adults, and children aged 12 and older, with hemophilia B. ALPROLIX is the first approved long-acting hemophilia B therapy and...